Is Our Yearlong 2025 Mazda CX-70 Actually Luxurious?
Mazda set its sights on evolving into a 'traditional mainstream premium' brand about a decade ago, aiming to carve out space as an alternative to non-German luxury makes like Lexus and Acura. Fast-forward to today, and we've seen that ambition come to life with the introduction of the CX-70 and the brand's new flagship, the CX-90. These SUVs clearly raise the bar for Mazda, delivering cabins that feel a step above the rest of the lineup, with sleek designs, thoughtful tech, and a more upscale experience overall. But the big question remains: Do they truly measure up to Japan's established luxury contenders?
0:00 / 0:00
After more than six months behind the wheel of our yearlong review 2025 Mazda CX-70 Turbo S Premium (plus 14 months in our previous CX-90 PHEV), we appreciate the brand's push upmarket—but it doesn't quite feel like we're driving a true luxury SUV. Sure, the premium interior and sleek styling have turned heads; friends and family have even asked, 'Wait, this is a Mazda?' But luxury is more than skin deep. It's not just about large screens and upscale materials, it's the way a vehicle drives, the refinement in its ride, and the overall sense of effortlessness that separates premium from mainstream. And in those areas, the CX-70 still has room to grow.
Where the CX-70 Feels Premium
Our long-term CX-70 is a near-loaded trim, powered by the robust 340-hp inline-six turbo engine. But it's inside the cabin where this SUV truly stands out. The dashboard is wrapped in leather, giving the interior a refined touch, while twin 12.3-inch displays—one for the infotainment system and the other for the digital gauge cluster—add a modern, high-tech feel. Our CX-70's Bose premium audio system is, well, premium, too. Altogether, these elements work in harmony to elevate the cabin experience and give the CX-70 a genuine sense of occasion.
Mazda also fits the CX-70 with a panoramic moonroof, three-zone climate control, heated and ventilated front seats, heated rear seats, plush Nappa leather upholstery, and second-row sunshades—all thoughtful touches that add comfort for everyone on board.
A few years ago, it would've been hard to imagine seeing features like these in a Mazda, but the brand's upmarket push is unmistakable. And we're glad to see it, especially when you factor in pricing. Our loaded CX-70 Turbo S Premium AWD rings in at $56,120, a few thousand bucks more than the starting prices of the 2026 Acura MDX and 2025 Lexus RX. Yet, the Mazda offers more horsepower and standard all-wheel drive, making it a strong value play in this segment.
Where the CX-70 Lags
As much as we appreciate the breadth of features our CX-70 offers at its competitive price, true luxury goes beyond the spec sheet. The driving experience matters—and matters a lot in this segment. The CX-70's 3.0-liter turbocharged inline-six has delivered some solid moments. It feels punchy, with minimal turbo lag, and the power is well matched to a vehicle of this size. With 340 hp and 369 lb-ft of torque, merging onto the highway is effortless. But it's not all smooth sailing. We've encountered noticeable hiccups from our Mazda's eight-speed automatic transmission and an unpolished stop/start system that detracts from the premium experience.
As MotorTrend Buyer's Guide director Zach Gale put it, 'Driving smoothly at low speeds shouldn't be so difficult.' We couldn't agree more. At speeds under 30 mph, the CX-70's transmission feels confused, hunting for the right gear and creating a noticeably unrefined experience. When it finally decides to shift, the changes can be abrupt and jarring—enough to cause head toss in the cabin and break the sense of composure. 'I see this as a real issue that could discourage a CX-70 owner from getting another one when a lease is up,' Gale added. And honestly, we've found ourselves wondering how this transmission setup cleared Mazda's own testing.
We've also experienced significant vibrations in the cabin when the start/stop system shuts off or restarts the engine. While the system is designed to let the CX-70 coast with the engine off under the right conditions, its behavior is inconsistent—like disengaging on the freeway while maintaining a steady speed. When that happens, the CX-70 begins to lose momentum, prompting us to press the throttle harder. That, in turn, triggers a jarring chain reaction: The engine restarts, the transmission downshifts abruptly, and only then does the vehicle regain speed.
These are two key areas where the CX-70 needs improvement if Mazda wants to truly compete with non-German premium brands. Winning over Acura and Lexus customers will require more than just attractive styling and strong value—it demands a smoother, more polished powertrain than Mazda currently offers. And let's be clear: Mazda isn't a newcomer trying to find its footing. This is an automaker with a rich history of building engaging performance-oriented vehicles. The CX-70 doesn't live up to that legacy yet—but we believe it can. And if it does, it'll be far better positioned to stand with established luxury rivals.
Last year, we spent time with a long-term 2024 Mazda CX-90 equipped with the plug-in hybrid powertrain—and we ran into multiple issues with its eight-speed transmission. It frequently shuddered, hesitated, and made abrupt shifts that disrupted the driving experience. On top of that, we found the steering overly heavy and the lane keeping assist system somewhat intrusive.
Bottom Line
Mazda is on the right track with its positioning of the CX-70 as a premium SUV, but the company still needs to sharpen the ride and powertrain experience. Sure, the cabin's clean design and the array of features make a strong first impression, but true luxury means more than just ticking boxes on an options list. The transmission quirks and stop/start system issues we've encountered hold the CX-70 back from delivering a fully refined experience. Ultimately, we'd enjoy the ride more in a Lexus or Acura—even if that meant paying a bit extra.
More On Our Long-Term Mazda CX-70:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Prediction: 1 Artificial Intelligence (AI) Stock to Buy Before It Soars 100% in the Next Year (Hint: Not Palantir)
CoreWeave shares have already tripled since the company held its initial public offering in March 2025. Research company SemiAnalysis recently recognized CoreWeave as the best GPU cloud on the market. CoreWeave's sales rose 420% in the first quarter, and that momentum could help the stock double in the next year. 10 stocks we like better than CoreWeave › Palantir Technologies (NASDAQ: PLTR) has been an incredible investment throughout the artificial intelligence (AI) boom. The stock has advanced 1,900% since January 2023. But CoreWeave (NASDAQ: CRWV) could be the next big winner as the AI boom continues to unfold. The company held its initial public offering two months ago, and the share price has already tripled, but I think CoreWeave stock can double again in the next year. Here's why. CoreWeave provides cloud infrastructure and software services. Its platform (called a GPU cloud) is purpose-built for demanding workloads like artificial intelligence (AI). Research company SemiAnalysis recently ranked CoreWeave as the best GPU cloud on the market, awarding it higher scores than competitors like Amazon, Microsoft, and Alphabet's Google. CoreWeave has distinguished itself from those hyperscalers in two ways. First, it is frequently the first cloud to deploy the latest Nvidia technologies due to its close relationship with the chipmaker. Second, CoreWeave is very good at running GPU clusters, such that it frequently achieves record-breaking results at the MLPerf benchmarks: objective tests that measure the performance of AI systems. CoreWeave reported tremendous first-quarter financial results. Revenue increased 420% to $981 million, and adjusted operating income (which excludes stock-based compensation and interest payments on debt) increased 550% to $162 million. As a caveat, the company reported a non-GAAP (generally accepted accounting principles) net loss of $150 million because interest payments on debt cut into profits. However, significant debt is unavoidable when building AI infrastructure, and CoreWeave has a responsible borrowing strategy involving what management calls "naturally deleveraging self-amortizing debt facilities." That means the company only takes on debt when a customer contract creates a need for additional AI infrastructure, and only if that contract more than covers the cost of the debt. CoreWeave disclosed an impressive customer list when it filed its Form S-1 with the SEC prior to its initial public offering, including IBM, Meta Platforms, Microsoft, and Nvidia. Since then, CoreWeave has won new contracts with OpenAI and an unnamed hyperscaler, such that the company now has a revenue backlog of nearly $26 billion. CoreWeave currently trades at 26 times sales. That is objectively expensive, but it seems reasonable for a company with triple-digit revenue growth and a gross margin of 73%. For instance, fellow cloud services company Cloudflare reported 27% revenue growth with a 77% gross margin in the most recent quarter, and that stock trades at 35 times sales. Here's why I think CoreWeave stock can double during the next year: Wall Street estimates trailing-12-month sales will grow 200% over the next four quarters. If that happens, shares can double while the price-to-sales ratio drops to a more reasonable 17. That seems plausible, provided demand for AI infrastructure remains robust. Before you buy stock in CoreWeave, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CoreWeave wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Trevor Jennewine has positions in Amazon, Nvidia, and Palantir Technologies. The Motley Fool has positions in and recommends Alphabet, Amazon, Cloudflare, International Business Machines, Meta Platforms, Microsoft, Nvidia, and Palantir Technologies. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Prediction: 1 Artificial Intelligence (AI) Stock to Buy Before It Soars 100% in the Next Year (Hint: Not Palantir) was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Court denies Apple's request to pause ruling on App Store payment fees
A U.S. court denied Apple a stay on a ruling that requires the company to stop charging developers for payments made outside the App Store through links in apps. This means in the U.S., Apple will no longer be able to charge developers a fee when customers click on a link within their app that takes them outside the App Store for payment, resulting in a potential loss of revenue to the company. "Apple 'bears the burden of showing that the circumstances justify an exercise of [our] discretion,'" the court said in a filing. "After reviewing the relevant factors, we are not persuaded that a stay is appropriate," it added. Epic Games' head Tim Sweeney applauded the court's ruling and said, "The long national nightmare of Apple tax is ended," in a post on X. In April, Judge Yvonne Gonzalez Rogers ruled in favor of Epic Games, saying that Apple was in 'willful violation' of a 2021 injunction that barred the company from forcing anticompetitive pricing. This essentially means that Apple must change the App Store rules and allow developers to freely link to their website for purchasing digital goods. In response, Apple filed an emergency motion last month seeking a stay on the court's ruling. The company also filed an appeal against the ruling around the same time. Last year, Apple began allowing other apps to link out and use non-Apple payment mechanisms, but it still took a 27% fee and added what critics called 'scare screens.' With the new ruling, both practices will be eliminated. Large companies are already making changes to their apps, with Spotify and Amazon publishing new updates that let users pay for their subscriptions and purchases outside the App Store. With the Worldwide Developer Conference (WWDC) slotted for next week, this is a big blow to Apple. Earlier this week, the company published a report saying that it generated $1.3 trillion in billings and sales in 2024. It added 90% of those sales didn't generate commission revenue for Apple.
Yahoo
an hour ago
- Yahoo
3D Printing Technology Revolutionizes Breast Implants Industry - A $4.6 Billion Market by 2030
Key players like Johnson & Johnson and Establishment Labs are driving innovation with FDA-approved products. Silicone implants lead the market due to their natural feel. North America dominates in market share, fueled by high awareness and cosmetic spending. Innovative trends like 3D printing are reshaping the industry. Breast Implants Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Breast Implants Market - Focused Insights 2025-2030" report has been added to Breast Implants Market was valued at USD 2.98 Billion in 2024, and is projected to reach USD 4.60 Billion by 2030, rising at a CAGR of 7.5%. The global breast implants market is set to grow due to the growing popularity of anatomical breast implants and generation-to-generation development in breast implants. KEY TAKEAWAYS By Product: The silicone breast implants segment holds the largest market share, as they are highly popular for offering a natural look and feel while maintaining shape even if ruptured. By Shape: The round shape segment shows the highest of 7.70%, as they are the most preferred breast implant shape category because they offer a fuller size across the breast area and limit the rotation of implants. By Surface: In 2024, the smooth surface segment accounted for the largest market share. Smooth surface breast implants are widely used for their natural feel and movement, enhancing effectiveness and reducing the need for repeat surgeries. By Application: The breast augmentation segment accounted for the largest market share. Breast augmentation is a top cosmetic surgery worldwide, with rising demand due to cosmetic and medical needs. By End-User: The cosmetology clinics segment holds the second largest market share of over 34%, driven by specialized, well-trained, well-experienced, and experienced plastic surgeons who regularly perform breast implant procedures in cosmetology clinics. By Geography: North America dominates the global breast implants market, with over 24% share. North America's breast implant market is growing steadily due to rising awareness, high beauty care spending, and interest in advanced procedures. BREAST IMPLANTS MARKET TRENDS & DRIVERS Rapid Development in Breast Implants with 3D Printing TechnologyThe breast implant industry is rapidly evolving with advancements in development and manufacturing technologies that create significant demand for breast implants. Of such one major development is the incorporation of 3D development technologies in the manufacturing and development of breast implants. It was started in the last decade when first-in-human clinical trials of 3D-printed breast implants (2019) were started in Germany, and now it is widespread across the global market. These 3D printing and development technologies offer the highest level of customization that attracts a significant consumer base. BellaSeno is one of the German companies that uses Evonik's Resomer polymer in its Senella breast implant (3D-printed) breast scaffold products. The polymer allows the scaffold to be absorbed in the body at a rate that matches the patient's Popularity of Anatomical Breast ImplantsRound shape breast implants are considered the gold standard for breast augmentation and reconstruction; however, in recent years, the development of anatomical implants has become an exciting trend in the industry. It involves the application of custom-molded implants that are designed and developed to mimic the shape and give a natural feel. Where anatomical breast implants become an ideal choice for women who are seeking to achieve a balanced look with a natural shape. Anatomical breast implants also known as tear-drop breast implants now commonly referred to as contour profile or shaped breast implants. These implants are filled with gel which gives a more natural feel and comfort making them the most popular choice among youngsters. These increasing applications in breast enlargement to breast implant exchange become popular for patients undergoing revision breast surgery, such as those patients who demand poly implant prostheses (PIP) implant Development in Breast ImplantsThe world of breast implants has witnessed significant and continued developments. Fourth and fifth-generation breast implants revolutionized the breast implant industry. In these generations, significant changes were noticed related to silicone gel cohesivity. In 4th and 5th generation breast implants, the shell of implants was further strengthened, and cohesive versions of silicone gel were used to significantly minimize complications related to gel leakage. In 5th-generation implants, they come up with highly form-stable gel that characterizes gummy bear implants. In addition, Establishment Lab - one of the key companies in the market came up with 6th generation breast implant. The company focused on a patient-centric approach in incorporating and developing revolutionary techniques in its Motiva product to enhance both safety and aesthetic outcomes- MOTIVA IMPLANTS. It is a first-of-their-kind feature that significantly revolutionizes the Volume of Breast Enhancement ProceduresWorldwide, with the widespread of cosmetology and medical aesthetic procedures, breast augmentation procedures become the second leading surgical cosmetic procedure. According to the International Society of Aesthetic Plastic Surgery (ISAPS) report 2024, more than 1.89 million breast augmentation procedures performed across the world contribute to significant demand for breast implants. Furthermore, the ISAPS article 2024 revealed that more than 4.1 million breast procedures were reported across the world. Of these, over 1.89 million surgical breast augmentation, around 903,266 breast lifts, approx. 686,000 breast reduction, and 335,939 breast implant removal procedures reported across the world. It indicates that the demand for breast surgeries is significantly high across the BREAST IMPLANTS MARKET SEGMENT INSIGHTS Key Market Segments Product: Silicone breast implants control the largest share, emphasizing their popularity for a natural appearance. Shape: Round shapes lead with a 7.70% growth rate, preferred for full-size enhancement and reduced implant rotation. Surface: Smooth surface implants dominate due to their natural feel and reduced need for replacements. Application: Breast augmentation claims the largest application share, fueled by rising cosmetic and medical demands. Geography: North America holds a dominant market share, driven by elevated awareness and advanced procedural needs. COMPETITIVE LANDSCAPEThe global breast implants market report consists of exclusive data on 13 vendors. AbbVie, Establishment Labs, Johnson & Johnson (MENTOR), GC Aesthetics, POLYTECH Health & Aesthetics, and Tiger Biosciences are among the leading companies holding a significant market share in the global breast implants market. These vendors offer high-quality and advanced breast implant solutions that meet customer demands and comply with regulatory standards. Major players are continuously enhancing the efficiency of their products and strengthening their market positions. They benefit from strong brand recognition and a broad geographical presence across global markets. Furthermore, the adoption of various strategic initiatives, such as product launches and the development of new products with advanced technologies and materials, has intensified market competition. By focusing on innovation and expanding their capabilities, these companies have successfully increased their revenue share and maintained a competitive edge in the breast implants Strategic Approaches to Strengthen Sales Ratios In 2025, Establishment Labs developed and launched Preserve, a minimally invasive breast tissue preserving technology for breast augmentation, mastopexy augmentation, and revision augmentation procedures. In 2024, the company established a manufacturing and corporate office in Costa Rica to increase the manufacturing capacity of breast implants and other products, which will create revenue growth opportunities. In 2024, Stratasys and CollPlant announced a collaboration to conduct a pre-clinical study for advanced and unique regenerative commercial-sized breast implants. With this collaboration, the companies reported that technology innovations will address around a $3 billion market opportunity in the future. In 2023, AbbVis' Allergen Aesthetics launched the Natrelle Campaign, which will promote and create awareness about the company's breast implant solutions with a higher level of customization. In 2023, Establishment Labs Holding announced the launch of Mia Femtech, a company that offers minimally invasive breast augmentation procedures in Japan to establish a new beginning in breast aesthetics. This expansion will deliver significant brand awareness about its breast implant solution in the Asian market. Key Vendors AbbVie Establishment Labs Johnson & Johnson (MENTOR) GC Aesthetics POLYTECH Health & Aesthetics Tiger Biosciences Other Prominent Vendors Bimini Health Tech Hans Biomed Guangzhou Wanhe Plastic Material Co., Ltd G.A.L.S. Private Limited Laboratoires Arion Sebbin Silimed Key Attributes: Report Attribute Details No. of Pages 136 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.98 Billion Forecasted Market Value (USD) by 2030 $4.6 Billion Compound Annual Growth Rate 7.5% Regions Covered Global Key Topics Covered: Chapter 1: Scope & Coverage: Breast Implants Market Overview Chapter 2: Breast Implants Market Premium Insights Key Highlights Regional Insights Chapter 3: Breast Implants Market Prospects & Opportunities Chapter 4: Breast Implants Market Industry Overview Projected Revenue of Breast Implants Market (2021-2030; $ Billions) Chapter 5: Breast Implants Market Segmentation Data Projected Revenue by Product (2021-2030; $ Billions) Silicone Saline Projected Revenue by Shape (2021-2030; $ Billions) Round Anatomical Projected Revenue by Surface (2021-2030; $ Billions) Smooth Textured Projected Revenue by Application (2021-2030; $ Billions) Breast Augmentation Breast Reconstruction Projected Revenue by End-user (2021-2030; $ Billions) Hospital Cosmetology Clinics Other End-user Chapter 6: Key Regions Overview Projected Revenue of Breast Implants Market (2021-2030; $ Billions) North America Europe Latin America APAC Middle East & Africa Chapter 7: Competitive Landscape of Breast Implants Market Competitive Landscape Key Vendor Profiles Other Prominent Vendors Key Strategic Recommendations For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Breast Implants Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
